DrugsControl Media Services

News Detail

IPC turns down CDSCO’s appeal for extension of timeline to implement IP 2022 (23-11-2022)

Mumbai, 23 Nov 2022: The Indian Pharmacopoeia Commission (IPC) has rejected Central Drugs Standard Control Organisation (CDSCO)’s request for extension of timelines to implement Indian Pharmacopoeia (IP) 2022.

Drugs Controller General of India (DCGI) Dr VG Somani......
View Details

Source : Pharmabiz
Indian Pharmacopoeia Commission IPC CDSCO Indian Pharmacopoeia IP 2022 DCGI phytopharmaceutical ingredient

Related News